Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Surg Endosc. 2023 Nov;37(11):8901-8909. doi: 10.1007/s00464-023-10438-7. Epub 2023 Oct 16.
Although radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma (PDAC) has become the gold standard procedure in open distal pancreatectomy, there has been no gold standardized procedure for PDAC in minimally invasive distal pancreatectomy (MIDP). In this study, we analyzed our novel cranial-to-caudal approach (CC approach) for patients undergoing MIDP and provide a video clip illustrating the details of the CC approach.
Ninety-four patients who underwent MIDP with splenectomy between 2016 and 2021 were included in this study. The CC approach was performed in 23 (24.5%) of the 94 patients. The concept of the CC approach is easy identification of Gerota's fascia from the cranial side of the pancreas and secure tumor removal (R0 resection) wrapped by Gerota's fascia. The short- and long-term outcomes were compared between the CC and non-CC approaches.
The median operation time and blood loss were similar between the two groups. The ratios of grade ≥ B postoperative pancreatic fistula and Clavien-Dindo grade ≥ III complications were also comparable. All patients in the CC approach group achieved R0 resection, and the R0 ratio was similar in the two groups (p = 0.345). The 2-year survival rate in CC and non-CC approach groups was 87.5% and 83.6%, respectively (p = 0.903).
The details of the CC approach for MIDP were demonstrated based on an anatomical point of view. This approach has the potential to become a standardized approach for left-sided PDAC.
尽管对于胰腺导管腺癌(PDAC)的开放性远端胰腺切除术而言,激进的顺行模块胰腺脾切除术已成为金标准术式,但微创远端胰腺切除术(MIDP)中 PDAC 仍未有金标准术式。本研究中,我们分析了采用 MIDP 并接受顺行到头侧入路(CC 入路)的患者,并提供了一段视频剪辑,详细展示了 CC 入路的步骤。
本研究纳入了 2016 年至 2021 年期间接受 MIDP 加脾切除术的 94 例患者。23 例(24.5%)患者采用 CC 入路。CC 入路的理念是从胰腺头侧易于识别肾筋膜,并安全切除包裹在肾筋膜内的肿瘤(R0 切除)。比较了 CC 入路与非 CC 入路的短期和长期结果。
两组的中位手术时间和出血量相似。两组术后胰瘘分级≥B 和 Clavien-Dindo 分级≥III 并发症的比例也相当。CC 入路组所有患者均达到 R0 切除,两组的 R0 切除率相似(p=0.345)。CC 入路组和非 CC 入路组的 2 年生存率分别为 87.5%和 83.6%(p=0.903)。
基于解剖学观点,展示了 MIDP 的 CC 入路的细节。该入路有可能成为左侧 PDAC 的标准入路。